KD Pharma Group completes acquisition of dsm-firmenich’s Marine Lipids business
The acquisition includes dsm-firmenich's Marine Lipids omega-3 fish oil business for the food and beverage, dietary supplement and pharmaceutical markets, ...
Read more
Etiket: Canada
KD Pharma Group to acquire dsm-firmenich’s marine lipids business in exchange for a minority stake in the company
The transaction expands KD Pharma Group‘s lipids CDMO business and includes the MEG-3® fish oil omega-3 product portfolio and two ...
Read more
“Epilepsy is Not Like What You Fear”
Epilepsy is a treatable brain disease caused by short-term brain dysfunction that affects approximately 1 percent of the world's population. ...
Read more